Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,221 | 146,443 | N/A | 277,200 | 365,700 |
| Marketable Securities | 54,627 | N/A | N/A | N/A | N/A |
| Receivables | N/A | N/A | N/A | 427,000 | 453,000 |
| Inventories | N/A | N/A | N/A | 1,843,300 | 1,763,000 |
| Other current assets | 0 | 0 | 0 | 342,600 | 320,900 |
| TOTAL | $94,544 | $148,275 | $N/A | $2,890,100 | $2,902,600 |
| Non-Current Assets | |||||
| PPE Net | 24,290 | 16,944 | N/A | 815,700 | 787,900 |
| Investments And Advances | 0 | 0 | 0 | 57,300 | 51,500 |
| Intangibles | 0 | 0 | 0 | 4,782,200 | 4,879,100 |
| Other Non-Current Assets | 37,265 | 1,793 | 0 | 39,400 | 55,000 |
| TOTAL | $61,555 | $18,737 | $N/A | $5,694,600 | $5,773,500 |
| Total Assets | $156,099 | $167,012 | $N/A | $8,584,700 | $8,676,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,846 | 21,101 | 0 | 241,700 | 264,000 |
| Accrued Expenses | 7,852 | 1,734 | N/A | N/A | N/A |
| Other current liabilities | 9,103 | 2,752 | N/A | 452,100 | 506,600 |
| TOTAL | $29,138 | $25,587 | $N/A | $706,600 | $1,250,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 2,024,500 | 2,024,900 |
| Other Non-Current Liabilities | 328,065 | 258,831 | 0 | 252,800 | 338,300 |
| TOTAL | $328,065 | $258,831 | $N/A | $2,804,000 | $2,816,200 |
| Total Liabilities | $357,203 | $284,418 | $N/A | $3,510,600 | $4,066,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 165,336 | 160,327 |
| Common Shares | 73 | 56 | N/A | 734,000 | 734,000 |
| Retained earnings | -203,044 | -124,718 | N/A | 6,352,600 | 6,136,800 |
| Other shareholders' equity | 16 | 0 | 0 | -146,700 | -186,300 |
| TOTAL | $-201,104 | $-117,406 | $N/A | $5,074,100 | $4,609,200 |
| Total Liabilities And Equity | $156,099 | $167,012 | $0 | $8,584,700 | $8,676,100 |